These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 21639778)

  • 1. Nonthrombogenic approaches to cardiovascular bioengineering.
    Li S; Henry JJ
    Annu Rev Biomed Eng; 2011 Aug; 13():451-75. PubMed ID: 21639778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelialization of cardiovascular devices.
    Jana S
    Acta Biomater; 2019 Nov; 99():53-71. PubMed ID: 31454565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of endothelial cell phenotype by biomimetic matrix coated on biomaterials for cardiovascular tissue engineering.
    Prasad CK; Krishnan LK
    Acta Biomater; 2008 Jan; 4(1):182-91. PubMed ID: 17643359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholesterol-modified polyurethane valve cusps demonstrate blood outgrowth endothelial cell adhesion post-seeding in vitro and in vivo.
    Stachelek SJ; Alferiev I; Connolly JM; Sacks M; Hebbel RP; Bianco R; Levy RJ
    Ann Thorac Surg; 2006 Jan; 81(1):47-55. PubMed ID: 16368333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonthrombogenic, adhesive cellular lining for left ventricular assist devices.
    Scott-Burden T; Tock CL; Bosely JP; Clubb FJ; Parnis SM; Schwarz JJ; Engler DA; Frazier OH; Casscells SW
    Circulation; 1998 Nov; 98(19 Suppl):II339-45. PubMed ID: 9852924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue-engineered vascular grafts composed of marine collagen and PLGA fibers using pulsatile perfusion bioreactors.
    Jeong SI; Kim SY; Cho SK; Chong MS; Kim KS; Kim H; Lee SB; Lee YM
    Biomaterials; 2007 Feb; 28(6):1115-22. PubMed ID: 17112581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The decellularized porcine heart valve matrix in tissue engineering: platelet adhesion and activation.
    Kasimir MT; Weigel G; Sharma J; Rieder E; Seebacher G; Wolner E; Simon P
    Thromb Haemost; 2005 Sep; 94(3):562-7. PubMed ID: 16268473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elastin as a nonthrombogenic biomaterial.
    Waterhouse A; Wise SG; Ng MK; Weiss AS
    Tissue Eng Part B Rev; 2011 Apr; 17(2):93-9. PubMed ID: 21166482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Invited commentary.
    Schlaudraff K
    Ann Thorac Surg; 2006 Jan; 81(1):56. PubMed ID: 16368334
    [No Abstract]   [Full Text] [Related]  

  • 10. Antithrombogenic property of bone marrow mesenchymal stem cells in nanofibrous vascular grafts.
    Hashi CK; Zhu Y; Yang GY; Young WL; Hsiao BS; Wang K; Chu B; Li S
    Proc Natl Acad Sci U S A; 2007 Jul; 104(29):11915-20. PubMed ID: 17615237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction of an autologous tissue-engineered venous conduit from bone marrow-derived vascular cells: optimization of cell harvest and seeding techniques.
    Roh JD; Brennan MP; Lopez-Soler RI; Fong PM; Goyal A; Dardik A; Breuer CK
    J Pediatr Surg; 2007 Jan; 42(1):198-202. PubMed ID: 17208565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrospun sulfated silk fibroin nanofibrous scaffolds for vascular tissue engineering.
    Liu H; Li X; Zhou G; Fan H; Fan Y
    Biomaterials; 2011 May; 32(15):3784-93. PubMed ID: 21376391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue-derived biomaterials and their use in cardiovascular prosthetic devices.
    Hilbert SL; Ferrans VJ; Jones M
    Med Prog Technol; 1988-1989; 14(3-4):115-63. PubMed ID: 2978589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Readily available tissue-engineered vascular grafts.
    Dahl SL; Kypson AP; Lawson JH; Blum JL; Strader JT; Li Y; Manson RJ; Tente WE; DiBernardo L; Hensley MT; Carter R; Williams TP; Prichard HL; Dey MS; Begelman KG; Niklason LE
    Sci Transl Med; 2011 Feb; 3(68):68ra9. PubMed ID: 21289273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo tissue engineering of heart valves: evolution of a novel concept.
    Schleicher M; Wendel HP; Fritze O; Stock UA
    Regen Med; 2009 Jul; 4(4):613-9. PubMed ID: 19580409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Development of the vascular prosthesis research].
    Zhu A; Shen J
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2003 Sep; 20(3):537-40. PubMed ID: 14565034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue engineering therapy for cardiovascular disease.
    Nugent HM; Edelman ER
    Circ Res; 2003 May; 92(10):1068-78. PubMed ID: 12775655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclic flexure and laminar flow synergistically accelerate mesenchymal stem cell-mediated engineered tissue formation: Implications for engineered heart valve tissues.
    Engelmayr GC; Sales VL; Mayer JE; Sacks MS
    Biomaterials; 2006 Dec; 27(36):6083-95. PubMed ID: 16930686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemocompatibility evaluation of poly(diol citrate) in vitro for vascular tissue engineering.
    Motlagh D; Allen J; Hoshi R; Yang J; Lui K; Ameer G
    J Biomed Mater Res A; 2007 Sep; 82(4):907-16. PubMed ID: 17335023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stem cells used for cardiovascular tissue engineering.
    Siepe M; Akhyari P; Lichtenberg A; Schlensak C; Beyersdorf F
    Eur J Cardiothorac Surg; 2008 Aug; 34(2):242-7. PubMed ID: 18468449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.